Amy Cheng
About Amy Cheng
Amy Cheng is a Research Coordinator at NYU Langone Health, specializing in the CTN-100 study on addictive disorders. She has a diverse background in research and quality assurance, with experience at Albert Einstein College of Medicine, SANY Foundation, and Poughkeepsie Medical Group.
Company
Amy Cheng is currently working at NYU Langone Health as a Research Coordinator. Her department is focused on aiding research and improving health outcomes through rigorous clinical investigations. NYU Langone Health is known for its cutting-edge research and state-of-the-art facilities, making it a top destination for medical professionals.
Title
As a Research Coordinator at NYU Langone Health, Amy Cheng coordinates the CTN-100 study. This study revolves around the diagnosis and treatment of addictive disorders by delving deeper into their root causes and physiological aspects. She ensures open communication between the research team, principal investigator, and site staff.
Background
Amy Cheng has a robust background in research coordination and quality assurance. She served as a Study Coordinator at Albert Einstein College of Medicine from 2018 to 2020. She also gained experience as a Social Policy Research Intern at SANY Foundation in Beijing in 2018. Additionally, she worked as a Quality Assurance Intern at Poughkeepsie Medical Group in 2017 and held the position of General Experience Associate at Exhale Spa from 2016 to 2017. Early in her career, she was a Peer Health Educator with Peer Health Exchange in New York.
Education and Expertise
Amy Cheng studied at City University of New York-Hunter College, where she achieved a Bachelor of Arts (B.A.) in Sociology. She also pursued Chinese Language and Literature at Hunter College. At Nanjing University, she studied Medical Sociology and Chinese. Her educational background is further supplemented by an academic stint at National Taiwan University in Chinese Language and Literature. Her expertise spans sociology, medical research, and quality assurance.
Achievements
One of Amy Cheng's significant roles involves coordinating the CTN-100 study at NYU Langone Health. This study aims to enhance the diagnosis and treatment of addictive disorders by exploring their physiological bases. She has also been responsible for preparing Institutional Review Board (IRB) materials, including protocol amendments and informed consents, ensuring compliance with rigorous research standards.